Athenex Pharma Solutions, LLC: Drug Recall
Recall #D-0706-2022 · 03/14/2022
Class II: Risk
Recall Details
- Recall Number
- D-0706-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Athenex Pharma Solutions, LLC
- Status
- Terminated
- Date Initiated
- 03/14/2022
- Location
- Clarence, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,270 bags
Reason for Recall
Defective container
Product Description
Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-474-15
Distribution Pattern
USA nationwide.
Other Recalls by Athenex Pharma Solutions, LLC
- Class II: Risk 03/14/2022
- Class II: Risk 03/14/2022
- Class II: Risk 03/14/2022
- Class II: Risk 03/14/2022
- Class II: Risk 03/14/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.